Free Trial

Aadi Bioscience (AADI) Competitors

Aadi Bioscience logo
$1.79 -0.03 (-1.65%)
As of 09/8/2025

AADI vs. BIOA, CYBN, DERM, ACTU, FTLF, CRBU, NLTX, VTYX, ALTS, and BTMD

Should you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include BioAge Labs (BIOA), Cybin (CYBN), Journey Medical (DERM), Actuate Therapeutics (ACTU), FitLife Brands (FTLF), Caribou Biosciences (CRBU), Neoleukin Therapeutics (NLTX), Ventyx Biosciences (VTYX), ALT5 Sigma (ALTS), and biote (BTMD). These companies are all part of the "pharmaceutical products" industry.

Aadi Bioscience vs. Its Competitors

Aadi Bioscience (NASDAQ:AADI) and BioAge Labs (NASDAQ:BIOA) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

In the previous week, BioAge Labs had 2 more articles in the media than Aadi Bioscience. MarketBeat recorded 3 mentions for BioAge Labs and 1 mentions for Aadi Bioscience. BioAge Labs' average media sentiment score of 0.15 beat Aadi Bioscience's score of 0.00 indicating that BioAge Labs is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aadi Bioscience
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioAge Labs
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

52.1% of Aadi Bioscience shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by insiders. Comparatively, 20.8% of BioAge Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Aadi Bioscience has higher revenue and earnings than BioAge Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aadi Bioscience$25.07M1.76-$65.76M-$2.35-0.76
BioAge LabsN/AN/A-$71.11MN/AN/A

BioAge Labs has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. BioAge Labs' return on equity of -25.39% beat Aadi Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Aadi Bioscience-246.06% -71.87% -57.28%
BioAge Labs N/A -25.39%-23.22%

Summary

BioAge Labs beats Aadi Bioscience on 5 of the 9 factors compared between the two stocks.

Get Aadi Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AADI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AADI vs. The Competition

MetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$44.21M$941.20M$5.83B$10.00B
Dividend YieldN/A4.84%5.28%4.53%
P/E Ratio-0.791.1275.6926.28
Price / Sales1.7626.60544.78188.18
Price / CashN/A19.5637.2059.76
Price / Book0.426.7511.506.41
Net Income-$65.76M-$4.20M$3.28B$270.56M
7 Day Performance-1.65%8.46%1.42%3.13%
1 Month Performance2.29%8.71%11.28%9.74%
1 Year Performance0.56%28.19%59.03%28.17%

Aadi Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AADI
Aadi Bioscience
N/A$1.79
-1.6%
N/A-1.1%$44.21M$25.07M-0.7940News Coverage
BIOA
BioAge Labs
N/A$4.93
+2.7%
N/AN/A$176.74MN/A0.00N/APositive News
CYBN
Cybin
2.5738 of 5 stars
$7.48
-2.1%
$85.00
+1,036.4%
N/A$176.45MN/A-1.7150Positive News
Gap Down
DERM
Journey Medical
1.9745 of 5 stars
$7.21
-0.8%
$12.17
+68.7%
+54.2%$175.77M$56.13M-18.9790
ACTU
Actuate Therapeutics
2.1065 of 5 stars
$8.44
+2.7%
$20.33
+140.9%
+2.9%$175.09MN/A0.0010
FTLF
FitLife Brands
3.6688 of 5 stars
$18.62
-0.3%
$22.00
+18.2%
+14.5%$174.86M$64.47M22.1720Positive News
CRBU
Caribou Biosciences
2.8572 of 5 stars
$1.87
-3.6%
$6.67
+256.5%
+4.2%$174.14M$9.99M-1.05100
NLTX
Neoleukin Therapeutics
N/A$18.48
-1.9%
N/A-44.4%$173.68MN/A-5.9490
VTYX
Ventyx Biosciences
2.7261 of 5 stars
$2.40
-2.0%
$7.50
+212.5%
+8.7%$171.14MN/A-1.4330
ALTS
ALT5 Sigma
0.4091 of 5 stars
$7.88
-5.6%
N/A+90.0%$170.28M$12.53M0.00170
BTMD
biote
3.2665 of 5 stars
$3.44
-0.9%
$6.00
+74.4%
-46.3%$170.07M$197.19M3.82194Positive News

Related Companies and Tools


This page (NASDAQ:AADI) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners